Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Bluebird bio Inc

Bluebird bio Inc

BLUE · NASDAQ
BLUE · NASDAQ
4.57
USD-0.40-8.14%

Latest News

    SeekingAlpha

    Carlyle, SK Capital Partners disclose expected closing date of bluebird bio deal

      SeekingAlpha

      Bluebird bio soars on amended deal with Carlyle, SK Capital

        SeekingAlpha

        bluebird bio confirms Ayrmid has not delivered binding offer, shares dive 9%

          SeekingAlpha

          Key deals this week: xAI acquires X; bluebird bio, Nvidia, Dollar Tree and more

            SeekingAlpha

            bluebird bio sees higher offer for company from Ayrmid Pharma

              SeekingAlpha

              bluebird bio stock slides for second day on buyout news

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              4.57USD
              5.03USD

              52 Week Range

              0.29USD
              10.28USD

              Market Cap

              48.67MUSD

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US09609G2093

              CUSIP

              09609G100

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              0.32

              Book Value

              -5.91

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -20.59

              Wall Street Target Price

              8.00

              EPS Estimate Current Year

              -11.28

              EPS Estimate Next Year

              -5.00

              EPS Estimate Current Quarter

              -4.635

              EPS Estimate Next Quarter

              -1.91

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              103,946,000

              Gross Profit TTM

              28,193,000

              EBITDA

              -149,196,000

              Profit Margin

              -192.39%

              Return On Assets TTM

              -28.37%

              Return On Equity TTM

              -546.54%

              Revenue Per Share TTM

              10.703

              Qtly Revenue Growth YOY

              108.40%

              Diluted Eps TTM

              -20.59

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              0

              Price Sales TTM

              0.4682

              Price Book MRQ

              0.726

              Enterprise Value Revenue

              1

              Enterprise Value EBITDA

              -1

              Peers analysis

              • CSL Limited
                CMXHFCSL Limited

                162.19

                6.58%
              • Be
                ONCBeiGene, Ltd.

                258.27

                2.78%
              • Alnylam Pharmaceuticals Inc
                ALNYAlnylam Pharmaceuticals Inc

                305.31

                0.55%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                447.41

                0.20%
              • Bo
                BBIXFBonus BioGroup Ltd

                0.00

                0.00%
              • UCB SA
                UCBJFUCB SA

                179.39

                0.00%
              • UCB SA ADR
                UCBJYUCB SA ADR

                90.68

                -2.58%
              • CSL Ltd
                CSLLYCSL Ltd

                79.74

                -1.56%
              • argenx NV ADR
                ARGXargenx NV ADR

                573.50

                -0.54%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                485.25

                -0.53%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Bluebird bio stock price today?

              What is Bluebird bio stock ticker?

              Is BLUE stock price going up?

              What is the analyst recommendation for BLUE?

              What is BLUE market cap?

              Does BLUE release financial reports?

              When is BLUE next earnings date?

              What were BLUE Earnings for the last quarter?

              What was BLUE Revenue for the last quarter?

              What was BLUE Net Income for the last quarter?

              Does BLUE pay dividends?

              How many employees does BLUE have?

              What is BLUE EBITDA?

              How to buy BLUE stocks?

              Should I invest in BLUE stock?